what happens if you have too much semaglutide to Do Inject 🔗 [LINK IN BIO] Read

In this study, GLP-1R expression increased with that of peroxisome proliferator-activated receptor- (PPAR-)

Elife 3 , e04047 (2014)

Mice received an intraperitoneal injection of 50% glucose solution at a dose of 2 g/kg body weight

The results indicated a significant increased risk of cholelithiasis with the use of GLP-1 RAs when compared to placebo or active comparator

Nausea and gastrointestinal symptoms peak during the first 1 to 2 weeks after this increase, then gradually improve as adaptation occurs

Buyer Takeaway: A weight-loss percentage attached to a compounded medication is describing the FDA-approved version's clinical data, not a study of the compounded product itself - a distinction worth remembering before you set expectations